Topic

Ohio

A collection of 479 issues

How to Get Gilenya (fingolimod) Covered by Blue Cross Blue Shield in Ohio: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Gilenya (fingolimod) Covered by Blue Cross Blue Shield in Ohio Fastest path to approval: Submit a comprehensive prior authorization through your BCBS Ohio provider portal including: 1) Complete prior MS therapy history with failure documentation, 2) Required safety tests (EKG, ophthalmologic exam, labs), and 3) First-dose monitoring
6 min read

UnitedHealthcare's Coverage Criteria for Kanuma (Sebelipase Alfa) in Ohio: What Counts as "Medically Necessary"?

Answer Box: Getting Kanuma Covered by UnitedHealthcare in Ohio UnitedHealthcare covers Kanuma (sebelipase alfa) for lysosomal acid lipase deficiency (LAL-D) with prior authorization required. To qualify, you need: confirmed LAL-D diagnosis (enzyme deficiency or LIPA gene variants), documented hepatic abnormalities (elevated ALT/AST, hepatomegaly), and evidence of failed supportive therapy
7 min read

How to Get Lamzede (velmanase alfa-tycv) Covered by Humana in Ohio: Complete PA Guide and Appeal Process

Answer Box: Getting Lamzede Covered by Humana in Ohio Fastest path to approval: Submit prior authorization through Humana's provider portal with confirmed alpha-mannosidosis diagnosis (enzyme assay + MAN2B1 genetics), functional assessments (6-minute walk test, pulmonary function), and specialist letter of medical necessity. Standard decisions take 30 days; expedited reviews
6 min read

How to Get Juxtapid (lomitapide) Covered by Aetna (CVS Health) in Ohio: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Juxtapid (lomitapide) Covered by Aetna (CVS Health) in Ohio Aetna (CVS Health) requires prior authorization for Juxtapid (lomitapide) with documented homozygous familial hypercholesterolemia (HoFH) diagnosis and evidence of failure or intolerance to preferred therapies. First step today: Gather genetic testing results or clinical HoFH documentation, baseline LDL-C
5 min read